Glooko and Danish digital therapeutics company Hedia have launched their combined diabetes care technology provision in the UK to enhance support for diabetic patients who require bolus insulin dosing ...

COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes‑tech company Hedia is implementing a leadership change effective 1 December 2025, when Rasmus Kofoed will take over as Chief Executive ...

Over 37 million Americans have diabetes, a disease that can have detremental effects on other parts of the body: 69% have high blood pressure, 44% have high cholesterol, 39% have chronic kidney ...

Diabetes management company Glooko is partnering with Copenhagen-based Hedia to integrate its app into Glooko's remote monitoring platform. The Hedia Diabetes Assistant allows patients to input their ...

Glooko Inc. and Hedia ApS launched an integrated software solution in the U.K. to support people with diabetes who require advanced doses of bolus insulin. The solution combines Glooko’s diabetes ...

COPENHAGEN, Denmark, Feb. 20, 2024 /PRNewswire/ -- Hedia announced today the appointment of their new CEO Lars Christian Lund. Lars has a strong track record of scaling market leading global MedTech ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif., Jan. 8, 2025 ...

COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes-tech company Hedia is implementing a leadership change effective 1 December 2025, when Rasmus Kofoed will take over as Chief Executive ...